Wound for Shire as Dermagraft fails in venous leg ulcers
This article was originally published in Scrip
Executive Summary
Shire's newly acquired tissue regenerative product Dermagraft has failed in a Phase III study in venous leg ulcers, and will no longer be developed for this chronic wound indication.